Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Net Income (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Net Income for 15 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 42.44% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Dec 2025, up 103.3% year-over-year, with the annual reading at $17.4 million for FY2025, 103.3% up from the prior year.
  • Net Income for Q4 2025 was $4.1 million at Niagen Bioscience, down from $4.6 million in the prior quarter.
  • The five-year high for Net Income was $7.2 million in Q4 2024, with the low at -$8.9 million in Q3 2021.
  • Average Net Income over 5 years is -$1.2 million, with a median of -$1.2 million recorded in 2022.
  • The sharpest move saw Net Income tumbled 110.11% in 2021, then soared 24160.0% in 2025.
  • Over 5 years, Net Income stood at -$5.3 million in 2021, then skyrocketed by 72.88% to -$1.4 million in 2022, then skyrocketed by 107.89% to $114000.0 in 2023, then skyrocketed by 6197.37% to $7.2 million in 2024, then plummeted by 42.44% to $4.1 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at $4.1 million, $4.6 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.